» Articles » PMID: 32582173

Imaging Technologies to Monitor the Immune System

Overview
Journal Front Immunol
Date 2020 Jun 26
PMID 32582173
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The past two decades have brought impressive advancements in immune modulation, particularly with the advent of both cancer immunotherapy and biologic therapeutics for inflammatory conditions. However, the dynamic nature of the immune response often complicates the assessment of therapeutic outcomes. Innovative imaging technologies are designed to bridge this gap and allow non-invasive visualization of immune cell presence and/or function in real time. A variety of anatomical and molecular imaging modalities have been applied for this purpose, with each option providing specific advantages and drawbacks. Anatomical methods including magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound provide sharp tissue resolution, which can be further enhanced with contrast agents, including super paramagnetic ions (for MRI) or nanobubbles (for ultrasound). Conjugation of the contrast material to an antibody allows for specific targeting of a cell population or protein of interest. Protein platforms including antibodies, cytokines, and receptor ligands are also popular choices as molecular imaging agents for positron emission tomography (PET), single-photon emission computerized tomography (SPECT), scintigraphy, and optical imaging. These tracers are tagged with either a radioisotope or fluorescent molecule for detection of the target. During the design process for immune-monitoring imaging tracers, it is important to consider any potential downstream physiologic impact. Antibodies may deplete the target cell population, trigger or inhibit receptor signaling, or neutralize the normal function(s) of soluble proteins. Alternatively, the use of cytokines or other ligands as tracers may stimulate their respective signaling pathways, even in low concentrations. As immune imaging is still in its infancy, this review aims to describe the modalities and immunologic targets that have thus far been explored, with the goal of promoting and guiding the future development and application of novel imaging technologies.

Citing Articles

Molecular MRI of T-cell immune response to cryoablation in immunologically hot . cold hepatocellular carcinoma.

Santana J, Shewarega A, Nam D, Duncan J, Madoff D, Hyder F JHEP Rep. 2025; 7(3):101294.

PMID: 40028344 PMC: 11870164. DOI: 10.1016/j.jhepr.2024.101294.


Discordant Responses Between Imaging Examination and Surgical Pathology of Head and Heck Squamous Cell Carcinoma After Neoadjuvant Immunotherapy Combined With Chemotherapy.

Ning Y, Song Y, He Y, Li H, Liu S World J Oncol. 2025; 16(1):59-69.

PMID: 39850520 PMC: 11750755. DOI: 10.14740/wjon1973.


In Vivo Visualization of Intravascular Patrolling Immune Cells in the Primate Eye.

Ashbery D, Baez H, Kanarr R, Kunala K, Power D, Chu C Invest Ophthalmol Vis Sci. 2024; 65(11):23.

PMID: 39283618 PMC: 11407476. DOI: 10.1167/iovs.65.11.23.


Artificial intelligence for response prediction and personalisation in radiation oncology.

Zwanenburg A, Price G, Lock S Strahlenther Onkol. 2024; 201(3):266-273.

PMID: 39212687 PMC: 11839704. DOI: 10.1007/s00066-024-02281-z.


Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging.

Lemdani K, Marlin R, Mayet C, Perkov V, Pascal Q, Ripoll M NPJ Vaccines. 2024; 9(1):113.

PMID: 38902327 PMC: 11189915. DOI: 10.1038/s41541-024-00900-5.


References
1.
Zhang Z, Li W, Procissi D, Li K, Sheu A, Gordon A . Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model. Radiology. 2014; 274(1):192-200. PMC: 4314117. DOI: 10.1148/radiol.14132172. View

2.
Mayer K, Mall S, Yusufi N, Gosmann D, Steiger K, Russelli L . T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target. Theranostics. 2019; 8(21):6070-6087. PMC: 6299443. DOI: 10.7150/thno.27275. View

3.
Li C, Liang S, Zhang C, Liu Y, Yang M, Zhang J . Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer. Biomaterials. 2015; 54:177-87. DOI: 10.1016/j.biomaterials.2015.03.024. View

4.
Pichler V, Berroteran-Infante N, Philippe C, Vraka C, Klebermass E, Balber T . An Overview of PET Radiochemistry, Part 1: The Covalent Labels F, C, and N. J Nucl Med. 2018; 59(9):1350-1354. DOI: 10.2967/jnumed.117.190793. View

5.
Signore A, Capriotti G, Chianelli M, Bonanno E, Galli F, Catalano C . Detection of insulitis by pancreatic scintigraphy with 99mTc-labeled IL-2 and MRI in patients with LADA (Action LADA 10). Diabetes Care. 2015; 38(4):652-8. DOI: 10.2337/dc14-0580. View